Attenuation Correction of Somatostatin Receptor SPECT by Integrated Low-Dose CT
- 1 December 2009
- journal article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 34 (12) , 869-873
- https://doi.org/10.1097/rlu.0b013e3181becfcb
Abstract
Somatostatin receptor scintigraphy (SRS) is an established imaging modality for neuroendocrine tumors (NET). Additional single photon emission computed tomography (SPECT-CT) not only permits image fusion but also attenuation correction (AC) of SPECT data. This study evaluated whether attenuation corrected SPECT-images (SPECT[AC]) are more sensitive than nonattenuation corrected SPECT-reconstructions (SPECT[NAC]) for the detection of NET lesions. The imaging data (planar In-111-octreotide scintigraphy and SPECT-CT) of 50 consecutive patients (28 male; 22 female; age, 34-80; mean, 65 years) with NET were included in this retrospective analysis. SPECT data were reconstructed with and without integrated CT-based AC and then analyzed by 2 experienced readers for the presence of pathologic uptake in a blinded consensus reading. Fused SPECT-CT, contemporary CT/MRI, and clinical as well as imaging follow-up served as a reference standard. All foci were rated in both the SPECT(NAC)- and SPECT(AC)-reconstructions for intensity and contrast using a 6-point-score ("0 = no uptake/no delineation from surrounding tissue" to "5 = very high uptake/very strong delineation from surrounding tissue"). The scores were analyzed in a 6 x 6 contingency table using the McNemar Bowker test. A total of 222 pathologic foci were detected by SPECT(NAC) and 227 foci by SPECT(AC), respectively. In 67 of 227 foci (29.5%), focus intensity/contrast increased after AC, whereas only 5 foci showed a decrease (P < 0.001). Sensitivity increased by 2.2% (P = 0.025; 95% CI: 0.02%-4.1%) as 5 foci were detected only by SPECT(AC). However, as these 3 patients were already diagnosed with systemic disease, there was no influence on the therapeutic strategy chosen. Attenuation correction of somatostatin receptor scintigraphy-SPECT significantly improves focus visualization and, albeit slightly, also significantly increases sensitivity.Keywords
This publication has 17 references indexed in Scilit:
- Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECTNuclear Medicine Communications, 2007
- Effect of CT-based attenuation correction on uptake ratios in skeletal SPECTNuklearmedizin-Nuclear Medicine, 2007
- The value of registration correction in the attenuation correction of myocardial SPECT studies using low resolution computed tomography imagesNuclear Medicine Communications, 2006
- Single-Photon Emission Computed Tomography/Computed Tomography: Basic Instrumentation and InnovationsSeminars in Nuclear Medicine, 2006
- The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumoursClinical Radiology, 2006
- Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumoursEuropean Radiology, 2004
- Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumoursActa Endocrinologica, 2004
- SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumoursClinical Endocrinology, 2003
- Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasmsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993